SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

FDC

BSE: 531599 29 Jun 2025
Healthcare
₹ 460
FDC Ltd. specializes in Pharmaceuticals within the Healthcare sector.

FDC - Share Price & Details

Market Cap
₹7,809
High /Low
659.0 / 359.0
Stock P/E
29.3
Book Value
₹140.0
Dividend Yield
1.04
ROCE
16.4
ROE
₹12.2
Face Value
1.0
PEG Ratio
11.6
EVEBITDA
₹18.7
Debt
21.2
CMP / FCF
55.2
Debt to equity
₹0.01
NP Ann
267
High price all time
659.0
Piotroski score
₹6.0
Graham Number
227.0
No. Eq. Shares
16.3
Net CF
₹25.9
Net profit
267
Price to book value
3.42
Interest Coverage
₹80.2
Low price all time
21.7
Industry PE
32.7
Reserves
₹2,265
Free Cash Flow
₹227

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
FDC LTD.NANANANA7,80929.3
Aarti Pharmalabs Limited5271.19888.455296.249.8779028.6
HealthCare Global EnterprisesNANANANA7595171.0

Peer Comparison Chart


About FDC

FDC Ltd., with Security Code 531599, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Volumes jump at FDC Ltd counter

(16 Jun 2025)
FDC Ltd saw volume of 1.5 lakh shares by 10:46 IST on BSE, a 18.81 fold spurt over two-week average daily volume of 7975 shares.
Read more →

Sterlite Technologies Ltd leads gainers in 'A' group

(16 Jun 2025)
Team Lease Services Ltd, FDC Ltd, P I Industries Ltd and UTI Asset Management Company Ltd are among the other gainers in the BSE's 'A' group...
Read more →

Has FDC declared dividend?

(07 Jun 2025)
FDC Ltd has declared a 500% dividend, amounting to ₹5 per share, with an ex-date of November 22, 2024. While recent returns have shown...
Read more →

FDC Limited's (NSE:FDC) Price Is Out Of Tune With Earnings

(31 May 2025)
There wouldn't be many who think FDC Limited's ( NSE:FDC ) price-to-earnings (or "P/E") ratio of 26.7x is worth a...
Read more →

FDC Faces Evaluation Shift Amid Declining Sales and Profit Performance

(31 May 2025)
FDC, a midcap pharmaceutical company, has recently experienced a change in its evaluation due to shifts in stock trends.
Read more →

FDC TO CONDUCT BOARD MEETING

(27 May 2025)
FDC will hold a meeting of the Board of Directors of the Company on 28 May 2025.
Read more →